• 1. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 2. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Recent Advances in the Application of 1-(Bromomethyl)-3-(difluoromethoxy)benzene (CAS: 72768-95-7) in Chemical Biology and Pharmaceutical Research

1-(Bromomethyl)-3-(difluoromethoxy)benzene (CAS: 72768-95-7) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of pharmaceuticals and agrochemicals. Recent studies have highlighted its utility in the construction of difluoromethoxy-containing molecules, which are increasingly important due to their enhanced metabolic stability and bioavailability. This research brief consolidates the latest findings on the applications, synthetic methodologies, and biological implications of this compound, providing valuable insights for researchers in the field.

A significant focus of recent research has been on the role of 1-(Bromomethyl)-3-(difluoromethoxy)benzene in the synthesis of novel kinase inhibitors. Kinases are critical targets in cancer therapy, and the introduction of difluoromethoxy groups has been shown to improve the selectivity and potency of these inhibitors. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy in the synthesis of EGFR inhibitors, with the difluoromethoxy moiety contributing to enhanced binding affinity and reduced off-target effects. The study utilized advanced computational modeling and X-ray crystallography to validate these findings.

In addition to its pharmaceutical applications, 1-(Bromomethyl)-3-(difluoromethoxy)benzene has been employed in agrochemical research. A recent report in ACS Agricultural Science & Technology detailed its use in the development of next-generation herbicides. The difluoromethoxy group was found to confer improved herbicidal activity and environmental stability, making it a promising candidate for sustainable agriculture. The study also explored the compound's metabolic pathways in plants, providing a foundation for future optimization.

From a synthetic chemistry perspective, advancements in the preparation of 1-(Bromomethyl)-3-(difluoromethoxy)benzene have been notable. A 2022 publication in Organic Letters introduced a novel, high-yield synthetic route using palladium-catalyzed cross-coupling reactions. This method not only improved the scalability of the compound but also reduced the reliance on hazardous reagents, aligning with the principles of green chemistry. Researchers emphasized the potential for this methodology to be adapted for other difluoromethoxy-containing intermediates.

Looking ahead, the versatility of 1-(Bromomethyl)-3-(difluoromethoxy)benzene continues to inspire innovation across multiple domains. Ongoing studies are exploring its utility in PET (positron emission tomography) tracer development, where the difluoromethoxy group's unique properties could enhance imaging resolution. Furthermore, collaborations between academia and industry are expected to accelerate the translation of these findings into practical applications, bridging the gap between basic research and clinical or agricultural use.

In conclusion, 1-(Bromomethyl)-3-(difluoromethoxy)benzene (CAS: 72768-95-7) remains a pivotal compound in chemical biology and pharmaceutical research. Its diverse applications, coupled with recent synthetic and methodological advancements, underscore its importance in the development of next-generation therapeutics and agrochemicals. Researchers are encouraged to leverage these insights to drive further innovation in their respective fields.

• 85684-64-6(1-(bromomethyl)-2-(difluoromethoxy)benzene)
• 261951-95-5(2-Methyl-4-(trifluoromethoxy)benzyl Bromide)
• 1261573-60-7(2-Methyl-5-(trifluoromethoxy)benzyl bromide)
• 3447-53-8(1-(bromomethyl)-4-(difluoromethoxy)benzene)
• 50824-05-0(4-(Trifluoromethoxy)benzyl bromide)
• 478484-53-6(2-METHOXY-5-(TRIFLUOROMETHOXY)BENZYL BROMIDE)
• 916420-55-8(3-Methyl-5-(trifluoromethoxy)benzyl Bromide)
• 159689-88-0(3-(Bromomethyl)trifluoromethoxybenzene)
• 1017779-39-3(5-(Difluoromethoxy)-3-fluorobenzyl bromide)
• 705-44-2(1-Methyl-3-(trifluoromethoxy)benzene)